Toggle Main Menu Toggle Search

Open Access padlockePrints

A combination of alfaxalone, medetomidine and midazolam for the chemical immobilization of Rhesus macaque (Macaca mulatta): Preliminary results

Lookup NU author(s): Henri Bertrand, Charlotte Sanders, Jennifer Murray, Emeritus Professor Paul FlecknellORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Background: Chemical immobilization of non-human primates can be required to perform scientific or veterinary procedure with different invasiveness degrees. This preliminary study was undertaken to assess the clinical effects of a combination of alfaxalone, medetomidine and midazolam (AMM). Methods: Seven rhesus macaques were chemically immobilized, for invasive veterinary procedures, with alfaxan 2 mg kg−1, medetomidine 20 μg kg−1 and midazolam 0.3 mg kg−1 injected subcutaneously. Results: The alfaxalone combination induced surgical anaesthesia, with a complete absence of response to noxious stimuli, for at least 20 minutes. The total duration of anaesthesia was 56 ± 7 minutes, and the administration of atipamezole, to partially reverse the combination effects, did not appear to alter the depth of anaesthesia. Conclusion: In conclusion, the AMM combination produced rapid onset general anaesthesia, following subcutaneous administration of a relatively low volume (0.28 mL/kg) of injectate.


Publication metadata

Author(s): Bertrand HGMJ, Sandersen C, Murray J, Flecknell PA

Publication type: Article

Publication status: Published

Journal: Journal of Medical Primatology

Year: 2017

Volume: 46

Issue: 6

Pages: 332-336

Print publication date: 01/12/2017

Online publication date: 21/09/2017

Acceptance date: 20/08/2017

ISSN (print): 0047-2565

ISSN (electronic): 1600-0684

Publisher: Blackwell Publishing Ltd

URL: https://doi.org/10.1111/jmp.12315

DOI: 10.1111/jmp.12315


Altmetrics

Altmetrics provided by Altmetric


Share